FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?

FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?

Source: 
Motley Fool
snippet: 
  • There isn't much overlap between Amgen's business and Horizons', but that isn't stopping the FTC from looking to block the deal.
  • Pfizer has a strong oncology portfolio and is planning to acquire Seagen, a company with an entire focus on cancer treatments.
  • Pfizer's deal is much larger than the Amgen-Horizons acquisition.